WELBIO is an inter-university life sciences research institute based in Wallonia, Belgium. WELBIO is funded by the Walloon Region. Our mission is to support strategic fundamental research through carefully selected projects from universities in the Wallonia-Brussels Federation, with a view to transforming their discoveries into industrial applications in all fields of biotechnology.
In a recent study published in PNAS, the team of Yves Dufrêne, FNRS research director and WELBIO investigator at the Université Catholique de Louvain, has elucidated, together with the Trinity College Dublin, the mechanism by which S. aureus responds to mechanical tension.
Research team led by Prof. Cédric Blanpain, MD/PhD, WELBIO investigator and Professor at the Université libre de Bruxelles (ULB), identified for the first time, the different tumor transition states occurring during cancer progression and identified subpopulations of tumor cells responsible for metastasis in skin squamous cell carcinoma, the second most frequent cancer worldwide, and breast cancer, the most frequent cancers in women. The results of this study have been published in Nature.
Researchers from the Université libre de Bruxelles, led by Cédric Blanpain (WELBIO investigator) and a team for the University of Cambridge (led by Berthold Göttgens), identified the role of key gene Mesp1 in the earliest step of cardiovascular lineage segregation. The results of this discovery that may help to better understand congenital heart defects, have been published in Science.